NCT02638311
Completed
Not Applicable
Using Normal Volunteer Whole Blood or Plasma Samples to Establish the 99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test
ConditionsAcute Coronary Syndrome
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Acute Coronary Syndrome
- Sponsor
- Trinity Biotech
- Enrollment
- 769
- Locations
- 3
- Primary Endpoint
- 99th percentile for Troponin results determined from whole blood and plasma in apparetly healthy volunteer population
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
Prospective multicenter sample collection and testing study.
Detailed Description
Prospective multicenter sample collection and testing study. Approximately 750 apparently healthy subjects, including healthy subjects with stable co-morbidities, age, gender and ethnicity dispersed will be eligible for enrollment
Investigators
Eligibility Criteria
Inclusion Criteria
- •Male or female at least 21 years of age at the time of enrollment in the study.
- •Subjects with no medications or no changes in their medications in the last 3 months.
- •Subjects with and without chronic stable morbidities (i.e., renal insufficiency, hypertension, diabetes, hypercholesterolemia, pulmonary disorders, coronary disease, musculoskeletal disorders, etc.).
- •Subjects able to understand and sign the informed consent and the patient questionnaire.
Exclusion Criteria
- •Subjects with a history of heart failure and/or, having received treatment for heart failure.
- •Subject with renal failure.
- •Subjects with a history of unstable heart disease or angina complaints.
- •Subjects with any change in their medication in the last 3 months (diabetics may have small variations in glucose medications but may not have unstable disease, or have suffered a diabetic crisis in the last 6 months).
- •Any known acute infection in the last 30 days.
- •Marathon runners or extreme athletes.
- •Pregnant (self-reported).
Outcomes
Primary Outcomes
99th percentile for Troponin results determined from whole blood and plasma in apparetly healthy volunteer population
Time Frame: 1 day
Study Sites (3)
Loading locations...
Similar Trials
Unknown
Not Applicable
Whole Blood Specimen Collection From Healthy SubjectsHealthy VolunteersNCT02797743Progenity, Inc.750
Completed
Not Applicable
Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular MarkersPreeclampsiaNCT02808494Illumina, Inc.242
Completed
Not Applicable
A Normal Donor Sample Collection Study in Healthy AdultsHealthy Normal VolunteersNCT01318863Astute Medical, Inc.300
Recruiting
Not Applicable
Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental ResearchNon Small Cell Lung CancerNCT05669105Sanguine Biosciences200
Completed
Phase 1
Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or RisperidoneImmunoassayAntipsychoticNCT02634463Janssen Research & Development, LLC81